Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Orchid Pharma Ltd.
Swot
Orchid Pharma Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Orchid Pharma Ltd. has 11 Strengths, 13 Weaknesses, 1 Opportunities and 2 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(11)
Weakness
(13)
Opportunity
(1)
Threats
(2)
Others
(5)
Benjamin Graham Value Screen
Expensive Performers (DVM)
PEG lower than Industry PEG
Relative Outperformance versus Industry over 1 Week
Companies with Low Debt
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Rising Delivery Percentage Compared to Previous Day and Month, Strong Volumes
Volume Shockers
Stocks Outperforming their Industry Price Change in the Quarter
Companies with growing costs YoY for long term projects
PE higher than Industry PE
High PE (PE > 40)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Degrowth in Revenue and Profit
Declining profits every quarter for the past 2 quarters
Low Piotroski Score : Companies with weak financials
Major fall in TTM Net Profit
Fall in Quarterly Revenue and Net Profit (YoY)
Profit to Loss Companies
High volume, top losers
Highest fall from 52 Week High
Top Losers
FII / FPI or Institutions increasing their shareholding
Red Flags: Firms linked to ongoing regulatory investigations/legal cases
MFs decreased their shareholding last quarter
Rising Delivery Percentage Compared to Prev Day
Rising Delivery Percentage Compared to Previous Day and Month, Strong Volumes
Average Financial Performers - Stocks with Medium Trendlyne Durability Score versus Benchmarks
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks
Decline in Net Profit with falling Profit Margin (QoQ)
